Join
Live feed
·
PRReleasevia Quantisnow
Merck & Company Inc. logo
Terns Pharmaceuticals Inc. logo

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

ByQuantisnow·Wall Street's wire, on your screen.
MRK· Merck & Company Inc.TERN· Terns Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRK (Merck & Company Inc.), TERN (Terns Pharmaceuticals Inc.) and more on Quantisnow.